TCL Archive Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer February 25, 2011
TCL Archive DCPC Board Asks More Money For Cancer Control In Centers, Urges Support Of Measure On Employment Discrimination October 3, 1986
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive “Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising. May 18, 2007
